TCERG1 anticorps (AA 701-800) (Cy5)
Aperçu rapide pour TCERG1 anticorps (AA 701-800) (Cy5) (ABIN721049)
Antigène
Voir toutes TCERG1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 701-800
-
Fonction
- TCERG1 Polyclonal Antibody, Cy5 Conjugated
-
Réactivité croisée
- Souris
-
Homologie
- Human,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human TCERG1/CA150
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- TCERG1 (Transcription Elongation Regulator 1 (TCERG1))
-
Autre désignation
- TCERG1
-
Sujet
-
Synonyms: Transcription elongation regulator 1, TATA box-binding protein-associated factor 2S, Transcription factor CA150, TCERG, CA150, TAF2S, TCRG1_HUMAN
Background: Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner. Necessary for TAT-dependent activation of the human immunodeficiency virus type 1 (HIV-1) promoter.
-
ID gène
- 10915
-
UniProt
- O14776
Antigène
-